Cite

HARVARD Citation

    Pollutri, D. et al. (n.d.). MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma. Digestive and liver disease. 49 (1), pp. e28-. [Online]. 
  
Back to record